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Abstract
Background—Previous research has documented an underuse of long-term control medications
among children with asthma, in non-adherence with national guidelines on asthma care.
Objectives—To determine if factors related to access and quality of asthma care are associated
with underuse of long-term control medication among children with asthma.
Research Design—A parent-report cross-sectional survey conducted in 26 randomly selected
New York City public elementary schools
Subjects—5,250 children, of whom 912 had asthma
Results—Twenty-nine percent of children with asthma reported using a long-term control
medication. Among children with persistent asthma, defined as having one or more sleep disturbances
due to asthma per week, 59.0% reported using a long-term control medication. After adjusting for
demographic factors, children who had an asthma plan, had visited a doctor in the previous 6 months
for non-urgent asthma care, or were enrolled in an asthma education program were more likely to
use long-term control medication (Odds Ratios:6.00, 4.11, 2.88, respectively). Children of Spanish-
speaking parents, African-American children, and children with no health insurance were the least
likely to use long-term control medication (Odds Ratios: 0.51, 0.49, 0.20, respectively). Children
who reported recommended components of asthma care were the most likely to use their medication
with appropriate frequency.
Conclusions—Children who reported markers of high quality, personalized medical care, were
more likely to use long-term control medication. These findings illustrate that components of the
medical care received, and not only the demographic characteristics of the patient, are key factors in
understanding the underuse of long-term control medication in urban children with asthma.
Introduction
Although the recommended treatment for asthma is well established, health outcomes among
children with asthma have been less than optimal.1 Current recommendations focus on a
combination of medications to address airway inflammation and constriction and avoidance
of environmental triggers.2 Yet, a number of studies have documented poor adherence to these
guidelines, resulting in the persistence of poor health outcomes and disparities in markers of
morbidity, especially among those of low socioeconomic status.3-6 In previous work, the
authors have found that almost half of a representative sample of urban children with asthma
had an urgent visit to the emergency department in the past 12 months.7 Latinos were five
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times as likely and African-Americans two times as likely as Whites to report urgent visits to
the emergency department.7 Deficiencies and disparities in quality of life and activity limitation
among children with asthma have been documented in other studies.8-9
The clinical guidelines set forth by the National Heart Lung and Blood Institute (NHLBI) aim
to improve asthma care in the United States by creating a standard of asthma treatment that is
based upon the best available medical knowledge.2 A key component of these guidelines is the
recommendation that all children with persistent asthma use long-term control medication.
Additionally, the guidelines recommend that these children and/or their parents should receive
counseling on the proper way to take these medications, including the importance of using
them in the absence of active symptoms.2 However, underuse of long-term control medications,
especially among minority children, continues to be a major impediment to successful asthma
management.10-14 A recent survey conducted by Halterman et al found that 37% of children
under the age of 18 with persistent asthma did not report receiving long-term control
medication.13 Research has shown that there is a problem of under-prescription of medication
by physicians6 as well as underuse of the medication by children, once it has been prescribed.
15,16
A number of studies have focused on characteristics of the child and their family as explanations
for medication non-adherence among patients.17-22 For example, previous research examining
racial/ethnic disparities in the use of long-term control medications has often discussed the role
of cultural beliefs, parental perceptions of asthma, and lack of health literacy as potential
explanations for why Latinos and African-Americans are less likely than Whites to use and
refill their medications.17,21,22 Yet, there have been few studies to examine whether
appropriate use of long-term control medication may be associated with other characteristics
of quality asthma care that minority children are less likely to receive.
A recent study of children under 18 found that minority children were less likely to report using
a controller medication and less likely to have an asthma management plan from their
physician, although the study did not determine if failing to have an asthma plan contributed
to the lack of medication use.14 Another study of children under 18 found that failing to have
an asthma plan was associated with having persistent symptoms and not reporting use of long-
term control medication.13 However, there are other factors related to health care access and
quality, besides having an asthma plan, that could impact a child's use of long-term control
medication. Additionally, these factors could also influence whether children use the
medication appropriately, i.e. regularly even when not having symptoms.
In the present study, we hypothesized that children who report markers of quality asthma care
will be more likely to use long-term control medication, independent of their socioeconomic
status. The objective of this study was to assess the factors associated with long-term control
medications in an ethnically and economically diverse sample of urban children. An additional
objective was to determine if communication barriers and education affect appropriate use of
medication.
Methods
Data were collected as part of a cross-sectional study of asthma prevalence during the
2002-2003 school year.23 The project was reviewed and approved by the Mount Sinai
Institutional Review Board, the Mount Sinai Health Insurance Portability and Accountability
Act Office and the New York City Department of Education's Division of Assessment and
Accountability.
Methodology for this study has been reported in previous publications.23,24 Briefly, New York
City ZIP Codes were ranked and grouped according to their childhood asthma hospitalization
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rate. To obtain a representative sample of New York City school children, the ZIP Codes within
the three groups with the highest, median, and lowest asthma hospitalization rates were eligible
for inclusion in the study. One public elementary school per eligible ZIP Code was randomly
selected with probability proportional to size. A total of 26 schools were selected, 8 within
each strata and two additional schools in the area of low asthma hospitalization to compensate
for the lower expected prevalence. To control for seasonality of asthma symptoms, which could
affect reported medication use, schools from each of the three groups were assessed
concurrently during overlapping 2-week periods, and so equal numbers of schools were
assessed during the fall, winter, and spring seasons.
Within each school, questionnaires were distributed in two randomly selected classrooms per
grade level, kindergarten through 5th grade, and up to two self-contained special education
classrooms where available. As described in a previous publication24, an interactive
presentation was given in each classroom, and children were instructed to bring the
questionnaire home to their parent/guardian and return the completed form within two weeks.
Both children and teachers were given nominal incentives, such as school supplies, to
encourage participation.
The parental questionnaire was adapted from a previous study of childhood asthma and was
available in English, Spanish, or Chinese.25 To ensure clarity and cultural appropriateness, the
questionnaire was pilot-tested among groups of native speakers, prior to the study. The
questionnaire contained standardized items on demographics, household environment, asthma
diagnosis and symptoms, medication use and healthcare utilization. Ever having asthma was
defined as a positive response to the following question, “Have you or your child ever been
told by a doctor or nurse that he/she has asthma?”. Children who also reported wheezing in the
previous 12 months were identified as having current asthma.
Because the NHLBI guidelines recommend long-term control medication for all children with
persistent asthma2, we sought to examine a subset of children who would fall into this category
based on their reported symptoms. The NHLBI classification scheme uses a combination of
day and nighttime symptoms, medication use, and lung function tests in order to categorize
asthma severity in a clinical setting.2 In this study, we used sleep disturbances due to asthma
as the marker for asthma severity. In order to be consistent with the NHLBI classification
scheme, children with a physician's diagnosis of asthma who also reported one or more sleep
disturbances due to asthma per week were designated “persistent”, requiring treatment with
long-term controller medication.
Use of medications, was ascertained by including a table of commonly prescribed medications
on the questionnaire and allowing respondents to indicate which medications their children
used during the past 2 weeks, as well as frequency of use. There was also an area where parents
could include medications not listed. For the purpose of this study, long-term control
medications included medications that fell into one of the following categories: long-term beta
agonists, inhaled corticosteroids, cromolyn, and leukotriene modifiers. The table also listed
commonly prescribed short-term beta-agonists and allergy medications. The response options
for frequency of use were: 1) when having symptoms only, 2) when having an attack only, or
3) regularly-even when not having symptoms.
To assess factors related to access to medical care, the questionnaire included items on
insurance status, access to medical advice on evenings or weekends, and whether the child had
a single, usual source of asthma care. Classifications for a single, usual source of medical care
for asthma included emergency departments, private physician's offices, community clinics/
hospital outpatient clinics, as well as not having a single, usual source of care. If more than
one location was indicated on the questionnaire, the respondent was classified as not having a
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single source of usual care and combined with the children who reported not having a usual
source of care. The rationale for collapsing these two categories is to be able to examine
consistency of care, and thus children with a single source of usual care are compared to
children who visit different places for their asthma care.
Markers of quality care were derived from the NHLBI guidelines. The following are all
included in the NHLBI guidelines as recommended components of quality asthma care: self-
management education for the patient and/or family, either through the child's physician or
other healthcare provider or program, such as community-based or school-based initiatives,
follow-up visits for routine asthma-care at intervals no greater than 6 months, and creating an
asthma management plan with a healthcare provider, that contains a component that addresses
appropriate medication use.2
Data were weighted to represent the number of children attending public elementary schools
within their respective ZIP Codes. All data analyses were conducted using the Surveymeans,
Surveyfreq, and Surveylogistic procedures in SAS v9.1(SAS Institute, Cary, NC, 2003). These
methods account for the clustering by school and stratification by neighborhood asthma
hospitalization rate in the sampling design.
Weighted percentages of demographic characteristics of the overall sample and of the subset
of children with asthma were calculated, as were the weighted prevalence of asthma and the
weighted percentage of children with asthma who reported current or persistent symptoms.
Long-term medication use in all children with ever asthma, current asthma and persistent
asthma was calculated and compared. To determine the socioeconomic and access to care
factors that were associated with long-term medication use, both unadjusted and adjusted odds
ratios and corresponding 95% confidence intervals (CI) were computed using logistic
regression procedures in SAS. Missing data were excluded from these calculations, and a
complete case analysis was performed. The multivariate model was constructed using variables
selected a priori based on literature review and plausible mechanistic theories.
Frequency of medication use was also examined in order to determine if children who reported
use of a long-term control medication used it appropriately, (regularly, even when not having
symptoms). A stratified analysis of weighted frequency of use, by access to care factors, was
conducted to determine if using medication regularly was more common among children who
reported communication and/or educational activities such as having an asthma management
plan that included when to take medications regularly and either the child or parent being
enrolled in an educational asthma program. Statistical comparisons between groups were made
by conducting chi-square tests corrected for the study design in SAS.
Results
As reported in our previous publications23,24, 5250 out of 7310 children returned a completed
questionnaire, yielding an absence-adjusted response rate26 of 76.9%. The demographic profile
of the study sample has been shown previously to be highly comparable to New York City
Department of Education's enrollment data for the participating schools, the 5-12 year old
population of the ZIP Codes from where the schools were selected, and the overall public
elementary school population of New York City.24
Demographic characteristics of the study participants
The demographic characteristics of the study participants are presented in Table 1. The sample
was ethnically diverse, with 39.2% of the children being Latino, 22.3% African-American,
15.2% White, 12.3% Asian, and 6.8% some other race/ethnicity, including multi-racial/ethnic
children. Almost two-thirds of the children lived in a household with an annual income less
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than $40,000. Only 5% lived in a household with an annual income of $75,000 or more. The
majority of children lived in a household where a parent/guardian had at least a high school
education or equivalency. Approximately 17% of children had their questionnaire completed
in a language other than English.
Demographic characteristics of children with asthma
The prevalence of ever having asthma was found to be 20.1% (17.2, 23.0 95% CI), representing
912 children. Children with asthma were more likely to be male or Puerto-Rican, and less likely
to be White or Asian (Table 1). Five hundred forty (60.5%) children with asthma reported
wheezing in the previous 12 months and were classified as having current asthma. Having
reported one or more sleep disturbances due to asthma per week, 16.5% (N=123) of the children
with asthma were categorized as persistent. Children with current and persistent asthma had
similar demographic profiles to children with asthma overall, although African-Americans
made up a larger percentage of persistent asthmatics than all asthmatics (African-Americans:
40.3%). Asians and children classified as Other made up a smaller percentage of children with
persistent asthma when compared to children with asthma overall (Asians: 2.66%, Other:
2.80%).
Prevalence of long-term control medication use
Among all children with asthma, 29.1% (25.8, 32.3 95% CI) reported use of a long-term control
medication in the previous 2 weeks, while 38.4% (33.5, 43.3 95% CI) of children with current
asthma reported medication use. As stated previously, NHLBI guidelines recommend that all
children with persistent asthma use a long-term control medication to treat their asthma.2
Among the subset of children with persistent asthma in our sample, only 59.0% (49.4, 68.7
95% CI) reported use of a long-term control medication. This data is illustrated in figure 1. Of
the 236 children with asthma who reported using a long-term control medication, 33.4% (24.8,
42.0 95% CI) had one or more sleep disturbances due to asthma per week, indicating that
despite being on a long-term control medication, their symptoms were not under control.
Factors associated with use of long-term control medication
Unadjusted and adjusted odds ratios for long-term controller use by demographic and access
to care factors are listed in Table 2. In unadjusted analyses, access and quality of care factors
were strongly associated with using long-term control medications. The greatest positive
association was observed among children whose parents had reported developing an asthma
management plan with their health care provider. They were six times as likely as children
who did not have a management plan to use long-term control medication (OR: 6.00 3.07, 11.7
95% CI). Enrollment in an asthma education program and visiting a physician in the previous
6 months for non-urgent care were also strongly associated with use of a long-term control
medication. Access to medical advice on evenings or weekends was not associated with use
of long-term control medication in unadjusted analysis (data not shown) and was not included
in the final adjusted model.
In the adjusted analysis, access to care factors were more strongly associated with long-term
control medication use than demographic factors. Similar to the unadjusted findings, children
in an asthma program, children who visited a physician in the last 6 months for non-urgent,
routine asthma care, and children who reported working out an asthma management plan with
their healthcare provider were all more likely to use long-term controller medication. Having
health insurance was also associated with using long-term control medication. Children with
no health insurance had very low odds of long-term medication use compared to children with
private insurance (OR: 0.20 0.04,1.09 95% CI). After adjusting for the above components of
medical care, children who reported not having a single source of asthma care or reported more
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than one usual source of care had the highest odds of using a long-term control medication
when compared to children who used the emergency department.
Completing the questionnaire in Spanish, which could indicate issues of communication with
non-Spanish speaking healthcare providers, also showed an independent association with
medication use, independent from the child's ethnicity. There were too few children with
asthma with a questionnaire completed in Chinese to provide a stable odds ratio estimate, but
the unadjusted estimate suggests that they too are less likely to use long-term control
medication than children from English-speaking families.
The adjusted analysis revealed some disparities in medication use based on demographic
factors. The odds ratio comparing medication use among African-Americans to Whites
changes from 1.07 in the unadjusted analysis to 0.49 in the adjusted analysis, indicating that
African Americans are less likely than Whites to use long-term controller medication, after
differences in access to care are taken into account. In both unadjusted and adjusted analyses
(not shown here), we found no association between parental educational attainment and
medication use. In both instances, the overall p-value was 1.0.
Communication/education factors and regular use of long-term control medication
Slightly more than half, 56.7%, of children with asthma who used a long-term controller
medication reported using it regularly, even when not having symptoms. Among children with
persistent asthma, , the percentage who used their long-term controller medication regularly
was 56.3%. Respondents who indicated enrollment in an asthma education program (n=60)
were more likely to use medication regularly than those who were not enrolled (n=194) (66.4%
vs 53.2%, p<0.0001). The difference was even greater when comparing children who had
worked out an asthma plan that included taking medications regularly, as 70.8% (n=177) of
those children reported taking their medication regularly, compared to only 25.4% (n=77) of
the children who either did not have any plan or whose plan did not include those specific
instructions (p<0.0001).
Discussion
This study documented an underuse of long-term control medication among urban children
with asthma, in non-adherence with the recommendations put forth by the NHLBI asthma care
guidelines. Additionally, markers of health care access and quality of care were found to be
highly associated with use of long-term control medications, independent of demographic
characteristics. These findings illustrate that components of the medical care received, and not
only the demographic characteristics of the patient, are key factors in understanding the
underuse of long-term control medication in urban children with asthma.
Our finding that more than 40% of children with persistent asthma did not report using a long-
term control medication is consistent with previous population-based studies, both using self-
report data13,14 and prescription data12, that document underuse of long-term medication
among children. One-third of all children with asthma in this sample who indicated use of a
long-term control medication reported experiencing frequent, nighttime symptoms. This
suggests that, despite using a long-term control medication, their asthma remains poorly
controlled. Some of these children may require more aggressive medication regimens or
additional counseling on the importance of reducing the presence of environmental allergens
and triggers.14 Both of these actions should be addressed as part of a comprehensive asthma
management plan, which the majority of children reported having. Thus, it is possible that
some of these plans may be incomplete and/or not updated frequently to address a child's
changing symptomology, potentially contributing to the finding that some children using long-
term control medications do not have well-controlled asthma.
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This study also found that markers of access and quality care were highly associated with long-
term control medication use. Previous work in children under 18 found similar results regarding
the association between having an asthma management plan and using long-term control
medication.13 However, our study also controlled for other medical care factors, such as type
of health insurance, a recent non-urgent physician visit and usual source of care, which we
found also contributed to long-term control medication use. Additionally, our study was able
to compare long-term control medication use in children of different socioeconomic
backgrounds, building upon previous work which focused on traditionally underserved
populations, such as Medicaid recipients.10,27
Children from Spanish-speaking households were less likely to use long-term control
medication than children from English-speaking households. Consistent with previous
research,14,28,29 this finding indicates communication-related and/or cultural barriers to
appropriate medication use and treatment that are independent of income, insurance status and
source of care. Our finding that children with multiple sources of care are more likely to use a
long-term control medication than children who reported having a single, source of usual care
may be explained by their increased contacts with different members of the health field. This
may give patients greater opportunity to be prescribed and/or counseled on long-term control
medication.
Our study also found that African-Americans were less likely to report long-term medication
use, after adjusting for factors related to access and quality of care. Previous work has suggested
that disparities in medication use between African-Americans and Whites may be due to lower
expectations of health outcomes among minority parents coupled with a greater concern about
using medication everyday, even in the absence of symptoms.22 Our study did not inquire about
complementary or alternative medical treatments, which previous research has found are more
common among minority families. Research suggests that African-Americans are more likely
to use alternative treatments in place of traditional medication,30-32 which may explain some
of the disparity between African-Americans and Whites observed in our study.
In addition to characterizing the factors associated with using long-term control medication,
this study examined whether children were taking the medication appropriately. The finding
that almost half of the children with a long-term control medication use it only when having
symptoms illustrates a lack of understanding among parents about how the medication works
to prevent symptoms before they start. It may also indicate a lack of communication between
physician and patient/family. This is supported by the finding that the parents who reported
having an asthma plan which specifically included a component on taking medications
regularly were the parents most likely to report that their child took the medication regularly.
After adjusting for access and quality of care factors, our study did not find associations
between long-term control medication use and either parental education level or household
income. In contrast, previous work has found that low-income children and children with
parents with lower levels of education are less likely to use long-term control medication for
their asthma.12-14,27 These studies did not control for some of the access and quality of care
factors that were included in the present analysis, which could explain the difference in our
findings. Although the income data suggest that children from middle-income families are
more likely to use long-term control medication than children from lower or upper income
families, the confidence intervals are very wide, preventing us from making substantive
conclusions about the relationship between income and medication use.
This study used self-report of medication use, as opposed to obtaining prescription data from
a pharmacy or medical record. It is possible that parents receive, but do not fill prescriptions
for long-term control medications for their children with asthma. Previous studies of
Stingone and Claudio Page 7













discordance between parent and physician report of medication prescription found that when
a physician reported a prescription for long-term control medication, more than one-third of
parents failed to report its use.15 While it may cause an underestimate of the number of children
who receive long-term control medication prescriptions, self-report data represents use of the
medication, which is an important marker on the pathway to optimal asthma management.
This study is limited by its cross-sectional design, which prevents drawing conclusions on
causality. Selection bias may also be a limitation because parents who responded to the survey
may have been different from those who chose not to participate. However, this limitation may
have been minimized by our high response rate and the finding that study sample was
demographically very similar to the selected schools' enrolled population, the population of
the ZIP Codes surrounding the schools, as well as the overall New York City public school
population.24 Thus, it is less likely that our findings are explained by selection bias. The use
of complete-case analysis in our multivariable regression model is another potential limitation,
as the exclusion of missing data caused the sample size of this analysis to be reduced. Even
with these potential limitations, these study results are generalizable to the overall New York
City pediatric population, as well as to children living in other US urban environments, which
share similar demographic profiles, insurance coverage, and asthma prevalence.
In conclusion, these findings stress the importance of continued education of physicians and
patients on the established standard of care for childhood asthma, including using long-term
control medication in the context of a comprehensive asthma management plan. Our study
shows that long-term control medications continue to be underutilized in the treatment of
childhood asthma. This study's results support providing a context of asthma management that
includes working on an asthma plan, scheduling non-urgent asthma check-ups, and providing
self-management education in order for children to use their medication and use it with
appropriate frequency.
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Percentage of children who reported use of a long-term control medication by asthma status.
Ever asthma defined as having received an asthma diagnosis from a physician or other
healthcare provider. Current asthma defined as having an asthma diagnosis and reporting
wheezing symptoms in the previous 12 months. Persistent asthma defined as having an asthma
diagnosis and reporting one or more sleep disturbances due to asthma per week.
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Table 1
Demographics of total sample and sub population of asthmatics, defined as having a physician's diagnosis of asthma
Overall Study Ever Asthmatics
Sample (N=5,250) (N=912)
Gender
% Male 46.8 54.4





Puerto Rican 12.1 23.2









$75,000 or more 5.3 3.4
Parental Education
Less than High School 19.5 22.5
High School/GED 28.6 31.4
Some College/trade 23.5 22.9
School
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